$KATX
KAT EXPLORATION, INC.

2023 Q3 Form 10-Q Financial Statement

#000168316823004909 Filed on July 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $560.00
YoY Change 5500.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $560.00 $43.10K $38.50K
YoY Change 5500.0% 11.95%
Operating Profit -$560.00 -$43.10K -$38.50K
YoY Change 5500.0% 11.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$560.00 -$43.10K -$38.50K
YoY Change 5500.0% 11.95%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$560.00 -$43.10K -$38.50K
YoY Change 5500.0% 11.95%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.834B shares 1.759B shares 1.794B shares
Diluted Shares Outstanding 1.834B shares 1.834B shares 1.794B shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $6.000K $6.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $6.560K $6.000K
YoY Change -62.8%
SHAREHOLDERS EQUITY
Retained Earnings -$2.725M -$2.724M
YoY Change 1.83%
Common Stock $1.834M $1.834M
YoY Change 2.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.560K -$6.000K -$17.63K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$560.00 -$43.10K -$38.50K
YoY Change 5500.0% 11.95%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001474558
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08589
dei Entity Registrant Name
EntityRegistrantName
KAT EXPLORATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2737873
dei Entity Address Address Line1
EntityAddressAddressLine1
2313 Hollyhill Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Denton
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76205
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
899-8518
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1834271048 shares
CY2023Q2 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Cash
Cash
125 usd
CY2023Q2 us-gaap Assets
Assets
0 usd
CY2022Q4 us-gaap Assets
Assets
125 usd
CY2023Q2 KATX Due To Related Parties Current1
DueToRelatedPartiesCurrent1
0 usd
CY2022Q4 KATX Due To Related Parties Current1
DueToRelatedPartiesCurrent1
19266 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
22266 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1834271048 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1834271048 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1794271048 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1794271048 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1834271 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1794271 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
884054 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
864100 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2724325 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2680513 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22142 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2023Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
43000 usd
CY2022Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
38501 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
43510 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
39626 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
100 usd
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
0 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
302 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
0 usd
CY2023Q2 KATX Sales Incentives
SalesIncentives
0 usd
CY2022Q2 KATX Sales Incentives
SalesIncentives
0 usd
KATX Sales Incentives
SalesIncentives
0 usd
KATX Sales Incentives
SalesIncentives
0 usd
CY2023Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
CY2022Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
CY2023Q2 us-gaap Depreciation
Depreciation
0 usd
CY2022Q2 us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
43100 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
38501 usd
us-gaap Operating Expenses
OperatingExpenses
43812 usd
us-gaap Operating Expenses
OperatingExpenses
39626 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-43100 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-38501 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-43812 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-39626 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43100 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38501 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43812 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39626 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-43100 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-38501 usd
us-gaap Net Income Loss
NetIncomeLoss
-43812 usd
us-gaap Net Income Loss
NetIncomeLoss
-39626 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares
us-gaap Net Income Loss
NetIncomeLoss
-43812 usd
us-gaap Net Income Loss
NetIncomeLoss
-39626 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
16267 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-4626 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60079 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59954 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-125 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1125 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-14125 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-38501 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-17626 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22142 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
19854 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-712 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
100 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-43100 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares

Files In Submission

Name View Source Status
0001683168-23-004909-index-headers.html Edgar Link pending
0001683168-23-004909-index.html Edgar Link pending
0001683168-23-004909.txt Edgar Link pending
0001683168-23-004909-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
katx-20230531.xsd Edgar Link pending
katx_ex3101.htm Edgar Link pending
katx_ex3102.htm Edgar Link pending
katx_ex3201.htm Edgar Link pending
katx_ex3202.htm Edgar Link pending
katx_i10q-053123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
katx-20230531_cal.xml Edgar Link unprocessable
katx_i10q-053123_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
katx-20230531_lab.xml Edgar Link unprocessable
katx-20230531_def.xml Edgar Link unprocessable
katx-20230531_pre.xml Edgar Link unprocessable